اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
CLOZAPINE از شرکت MYLAN
Abbreviated New Drug Application (ANDA): 201824
Company: MYLAN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CLOZAPINE | CLOZAPINE | 12.5MG | TABLET, ORALLY DISINTEGRATING;ORAL | None (Tentative Approval) |
None |
No | No |
| CLOZAPINE | CLOZAPINE | 25MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription |
AB |
No | No |
| CLOZAPINE | CLOZAPINE | 100MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription |
AB |
No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/15/2015 | ORIG-2 | Tentative Approval |
Not Applicable |
|
Label is not available on this site. |
||
| 09/15/2015 | ORIG-1 | Approval |
Not Applicable |
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/201824Orig1s000ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 07/29/2021 | SUPPL-15 | REMS – MODIFIED – D-N-A |
Label is not available on this site. |
||
| 02/18/2021 | SUPPL-13 | REMS – MODIFIED – D-N-A |
Label is not available on this site. |
||
| 07/26/2020 | SUPPL-11 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/16/2019 | SUPPL-9 | REMS – MODIFIED – D-N-A |
Label is not available on this site. |
||
| 11/17/2017 | SUPPL-7 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/22/2016 | SUPPL-5 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/22/2016 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
CLOZAPINE
TABLET, ORALLY DISINTEGRATING;ORAL; 25MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| CLOZAPINE | CLOZAPINE | 25MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription | No | AB | 090308 | BARR LABS INC |
| CLOZAPINE | CLOZAPINE | 25MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription | No | AB | 201824 | MYLAN |
TABLET, ORALLY DISINTEGRATING;ORAL; 100MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| CLOZAPINE | CLOZAPINE | 100MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription | No | AB | 090308 | BARR LABS INC |
| CLOZAPINE | CLOZAPINE | 100MG | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription | No | AB | 201824 | MYLAN |
نظرات کاربران